Circulating cell-free DNA as potential diagnostic tools for amyotrophic lateral sclerosis

Philippe Pierre Robichaud; Michael Arseneault; Colleen O'Connell; Rodney J. Ouellette; Pier Jr Morin

doi:10.1016/j.neulet.2021.135813

Circulating cell-free DNA as potential diagnostic tools for amyotrophic lateral sclerosis

Philippe Pierre Robichaud, Michael Arseneault, Colleen O'Connell, Rodney J. Ouellette, Pier Jr Morin

Résultat de recherche: Article › examen par les pairs

7 Citations (Scopus)

Résumé

DNA methylation has garnered much attention in recent years for its diagnostic potential in multiple conditions including cancer and neurodegenerative diseases. Conversely, advances regarding the potential diagnostic relevance of DNA methylation status have been sparse in the field of amyotrophic lateral sclerosis (ALS) even though patients diagnosed with this condition would significantly benefit from improved molecular assays aimed at furthering the current diagnostic and therapeutic options available. This review will provide an overview of the current diagnostic approaches available for ALS diagnosis and discuss the potential clinical usefulness of DNA methylation. We will also present examples of DNA methylation as a diagnostic tool in various types of cancer and neurodegenerative conditions and expand on how circulating cfDNA methylation may be leveraged for the early detection of ALS. In general, this article will reinforce the importance of cfDNA methylation as diagnostic tools and will further highlight its clinical relevance for persons diagnosed with ALS.

Langue d'origine	English
Numéro d'article	135813
Journal	Neuroscience Letters
Volume	750
DOI	https://doi.org/10.1016/j.neulet.2021.135813
Statut de publication	Published - avr. 17 2021
Publié à l'externe	Oui

Note bibliographique

Funding Information:
Experimental work on diagnostic tools relevant to ALS was supported by an ALS Canada and Brain Canada Discovery Grant awarded to COC, RJO and PJM. PPR was supported by the Mitacs Elevate postdoctoral fellowship program .

Publisher Copyright:
© 2021 Elsevier B.V.

ASJC Scopus Subject Areas

General Neuroscience

PubMed: MeSH publication types

Journal Article
Research Support, Non-U.S. Gov't
Review

ODD de l’ONU

Cette action contribue à la réalisation des objectifs de développement durable suivants

Accès au document

10.1016/j.neulet.2021.135813

Autres fichiers et liens

Citer

@article{4ad87718edc740cdba908535a3a138ff,

title = "Circulating cell-free DNA as potential diagnostic tools for amyotrophic lateral sclerosis",

abstract = "DNA methylation has garnered much attention in recent years for its diagnostic potential in multiple conditions including cancer and neurodegenerative diseases. Conversely, advances regarding the potential diagnostic relevance of DNA methylation status have been sparse in the field of amyotrophic lateral sclerosis (ALS) even though patients diagnosed with this condition would significantly benefit from improved molecular assays aimed at furthering the current diagnostic and therapeutic options available. This review will provide an overview of the current diagnostic approaches available for ALS diagnosis and discuss the potential clinical usefulness of DNA methylation. We will also present examples of DNA methylation as a diagnostic tool in various types of cancer and neurodegenerative conditions and expand on how circulating cfDNA methylation may be leveraged for the early detection of ALS. In general, this article will reinforce the importance of cfDNA methylation as diagnostic tools and will further highlight its clinical relevance for persons diagnosed with ALS.",

author = "Robichaud, {Philippe Pierre} and Michael Arseneault and Colleen O'Connell and Ouellette, {Rodney J.} and Morin, {Pier Jr}",

note = "Funding Information: Experimental work on diagnostic tools relevant to ALS was supported by an ALS Canada and Brain Canada Discovery Grant awarded to COC, RJO and PJM. PPR was supported by the Mitacs Elevate postdoctoral fellowship program . Publisher Copyright: {\textcopyright} 2021 Elsevier B.V.",

year = "2021",

month = apr,

day = "17",

doi = "10.1016/j.neulet.2021.135813",

language = "English",

volume = "750",

journal = "Neuroscience Letters",

issn = "0304-3940",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Circulating cell-free DNA as potential diagnostic tools for amyotrophic lateral sclerosis

AU - Robichaud, Philippe Pierre

AU - Arseneault, Michael

AU - O'Connell, Colleen

AU - Ouellette, Rodney J.

AU - Morin, Pier Jr

N1 - Funding Information: Experimental work on diagnostic tools relevant to ALS was supported by an ALS Canada and Brain Canada Discovery Grant awarded to COC, RJO and PJM. PPR was supported by the Mitacs Elevate postdoctoral fellowship program . Publisher Copyright: © 2021 Elsevier B.V.

PY - 2021/4/17

Y1 - 2021/4/17

N2 - DNA methylation has garnered much attention in recent years for its diagnostic potential in multiple conditions including cancer and neurodegenerative diseases. Conversely, advances regarding the potential diagnostic relevance of DNA methylation status have been sparse in the field of amyotrophic lateral sclerosis (ALS) even though patients diagnosed with this condition would significantly benefit from improved molecular assays aimed at furthering the current diagnostic and therapeutic options available. This review will provide an overview of the current diagnostic approaches available for ALS diagnosis and discuss the potential clinical usefulness of DNA methylation. We will also present examples of DNA methylation as a diagnostic tool in various types of cancer and neurodegenerative conditions and expand on how circulating cfDNA methylation may be leveraged for the early detection of ALS. In general, this article will reinforce the importance of cfDNA methylation as diagnostic tools and will further highlight its clinical relevance for persons diagnosed with ALS.

AB - DNA methylation has garnered much attention in recent years for its diagnostic potential in multiple conditions including cancer and neurodegenerative diseases. Conversely, advances regarding the potential diagnostic relevance of DNA methylation status have been sparse in the field of amyotrophic lateral sclerosis (ALS) even though patients diagnosed with this condition would significantly benefit from improved molecular assays aimed at furthering the current diagnostic and therapeutic options available. This review will provide an overview of the current diagnostic approaches available for ALS diagnosis and discuss the potential clinical usefulness of DNA methylation. We will also present examples of DNA methylation as a diagnostic tool in various types of cancer and neurodegenerative conditions and expand on how circulating cfDNA methylation may be leveraged for the early detection of ALS. In general, this article will reinforce the importance of cfDNA methylation as diagnostic tools and will further highlight its clinical relevance for persons diagnosed with ALS.

UR - http://www.scopus.com/inward/record.url?scp=85102657398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85102657398&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2021.135813

DO - 10.1016/j.neulet.2021.135813

M3 - Article

C2 - 33705931

AN - SCOPUS:85102657398

SN - 0304-3940

VL - 750

JO - Neuroscience Letters

JF - Neuroscience Letters

M1 - 135813

ER -

Circulating cell-free DNA as potential diagnostic tools for amyotrophic lateral sclerosis

Résumé

Note bibliographique

ASJC Scopus Subject Areas

PubMed: MeSH publication types

ODD de l’ONU

Accès au document

Autres fichiers et liens

Empreinte numérique

Citer